The cluster is small and mixed, with Dimensional's large trim offsetting modest adds. The 45-day reporting lag means these Q3-end positions may already be stale. Monitor next 13F for whether the buying or selling trend continued into Q4.
GKOS drugs
GKOS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $246.70entry
- T+1 · 12d ago −10.83%α −6.42% · $219.98
- T+5 · 6d ago +0.19%α +1.10% · $247.16
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
In Q3 2026, five small-to-mid-sized asset managers added GKOS positions (net +$5.5M) while three trimmed (net -$6.7M), with Dimensional Fund Advisors accounting for the bulk of selling. The cluster is mixed in direction and modest in scale, occurring after Glaukos reported record Q3 revenue (+58% YoY) and raised FY 2026 guidance, but with no insider buying corroboration.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.2M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Strs Ohio | DOUBLED | +150% | $3.4M | $2.2M |
| Creative Planning | ADD | +31.4% | $8.1M | $2.8M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Dimensional Fund Advisors | TRIM | -59.8% | $12.2M | -$6.4M |
Key Facts
- 5 buyers added $5.5M net; 3 sellers reduced $6.7M net; aggregate net selling of $1.2M
- Dimensional Fund Advisors trimmed 52.2K shares (-59.8%), accounting for $6.4M of the $6.7M total selling
- Strs Ohio doubled its position (+150%, +$2.2M); Creative Planning added 31.4% (+$2.8M)
- All participants are asset managers; no activist, hedge fund, or insider buying present
- Filing follows Q3 2026 earnings (10/28): record revenue $211M (+58% YoY), GAAP net income $2M, raised FY 2026 guidance to $775M-$785M
Financial Impact
5 institutions accumulated $5.5M in new positions while 3 reduced holdings by $6.7M; net cluster outflow of $1.2M against a $14.1B market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound or reversed
- No insider buying corroboration (confluence score 17/100, divergent)
- Dimensional's large trim could indicate a thesis change not visible in the filing
- Cluster dominated by small asset managers; signal strength is limited
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-GKOS-2026-Q3 |
Track record
16 reports on GKOS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 settles Nov 23
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 settles Nov 20
- Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 ▲ +9.50% +6.90% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $224.41 to $245.72 ▲ +9.50% +6.90% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 ▲ +0.19% +1.10% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Viewing Entry $246.70 to $247.16 ▲ +0.19% +1.10% vs SPY
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 ▼ −5.55% −2.85% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 ▼ −9.28% −4.55% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 ▲ +0.20% +1.56% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 ▲ +1.56% +2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers